Sanofi (SNY) Financials
SNY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 139.8 billion | 57.6 billion |
| 2023-09-30 | ? | ? |
| 2023-06-30 | 136.3 billion | 57.0 billion |
| 2023-03-31 | ? | ? |
SNY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 5.1 billion | -6.5 billion |
| 2023-09-30 | ? | ? |
| 2023-06-30 | 2.6 billion | 174.0 million |
| 2023-03-31 | ? | ? |
SNY Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 2.2 billion |
| 2023-09-30 | 2.7 billion |
| 2023-06-30 | 3.7 billion |
| 2023-03-31 | 2.2 billion |
SNY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 9.6 billion | - | 2.2 billion |
| 2023-09-30 | 8.5 billion | - | - |
| 2023-06-30 | 8.7 billion | - | 2.3 billion |
| 2023-03-31 | 13.9 billion | - | - |
SNY Shares Outstanding
SNY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.3 billion | 3.9 billion | 3.2 billion | - |
| 2023-09-30 | - | 1.8 billion | 2.7 billion | - |
| 2023-06-30 | 1.2 billion | 1.8 billion | 2.8 billion | - |
| 2023-03-31 | - | 1.7 billion | 2.8 billion | - |
SNY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 25.3 billion | 9.1 billion |
| 2023-09-30 | 13.4 billion | 4.1 billion |
| 2023-06-30 | 11.6 billion | 3.6 billion |
| 2023-03-31 | 11.8 billion | 3.4 billion |
SNY
Price: $49.23
Dividend Yield: 0.08%
Forward Dividend Yield: 4.14%
Payout Ratio: 87.44%
Dividend Per Share: 2.04 USD
Earnings Per Share: 2.29 USD
P/E Ratio: 19.91
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 337528
Ebitda: 1.5 billionMarket Capitalization: 116.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: 2.98%
DGR5: 0.64%
DGR10: 0.61%